| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |